Abstract
BackgroundImmune checkpoint therapy associated myocarditis (ICT-My) is a fatal immune-related adverse event (irAE) with a reported mortality rate of up to 50%.1 2 Neuromuscular adverse events (NMAEs), including myositis and...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have